AI in Drug Discovery Market By Component (Software, Service), Technology (ML, DL), By Application (Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and Other Applications), By End User (Pharmaceutical & Biotechnology, CRO, and Research Centers and Academic & Government Institutes), By Geography (North America, Europe, APAC, and RoW) Global Opportunity Analysis and Industry Forecast up to 2026

July 2020 | 88 pages | ID: ACEC65024B97EN
IHR Insights

Abstracts

AI in Drug Discovery Market By Component (Software, Service), Technology (ML, DL), By Application (Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and Other Applications), By End User (Pharmaceutical & Biotechnology, CRO, and Research Centers and Academic & Government Institutes), By Geography (North America, Europe, APAC, and RoW) Global Opportunity Analysis and Industry Forecast up to 2026

Artificial intelligence is the simulation of human intelligence in machines that are designed to think like humans and copy their actions. This gives potential to transform the pharmaceutical industry as well. Many pharma competitors are now investing in this technology at some level.

Research Methodology:

The AI in drug delivery market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

There is a significant increase in the number of applications that focuses on the target and drug discovery, preclinical and clinical development, and post approval activities. AI can help in improving the drug approval rates, reduce development costs, swift availability of medications and help patients comply with their treatments. The global AI in the drug discovery market has a high demand due to its increasing need to shorten the drug discovery process in order to get drugs faster for treating various incurable and viral diseases. Moreover, AI plays an important role to understand the mechanism of disease by determining biomarkers and creating data or models for the drug discovery process which will ultimately drive the market over the next few years.

To use the opportunity of diversifying the drug pipelines, AI-enabled prediction tools can improve the speed, accuracy, and preclinical testing and also it can open new research leads by availing more competitive R&D strategies. Failure to demonstrate value compared to available therapies is a key factor undermining clinical trial progression. Finding new niches of competitive advantage could reduce withdrawals and improve asset sales.

AI in drug discovery research report is segregated into following segments:

By Component

• Software
• Services

By Technology

• Machine Learning
• Deep Learning

By Application

• Immuno-oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• Other Applications

By End User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Research Centers and Academic & Government Institutes

The market value of AI in Drug Discovery recorded in 2020 is $343.78 million and predictions are made on its future growth at a CAGR of 43.24%. There are four major factors which are the result of its increasing growth:

• Requisite control on Cost and Time of Drug Discovery & Development
• Demanding requirement of precision medicine
• Expanding Cross-Industry Collaborations and Partnerships
• Growing number of troublemakers of AI drug discovery

AI in drug discovery has enlightened the productivity of medical facilities, and on the same page has helped in boosting care facilities. Extensive medical facilities always try to opt for better services and latest technologies with minimum space for mistakes. This technology has fastened the drug construction procedures for cases which need specialized medicinal attention, which subsequently decreases failure risks and also the cost of research & development procedures.

Some of the vital players within the space of AI in Drug Discovery are as follows:

• IBM Corporation
• Microsoft Corporation
• Google Inc.
• NVIDIA Corporation
• Pfizer, Merck
• GSK
• Novartis
• AstraZeneca
• Abbvie
• Elli Lilly
• Atomwise, Inc
• Deep Genomics
• Cloud Pharmaceuticals
• Exscientia
• Cyclica
• Numerate
• Envisagenics
• OWKIN, Inc.
• Verge Genomics

Another important factor of reducing the drug price has pressured the drug manufacturers to boost the production of AI for the drug discovery market. Efficient working of AI reduced the failure rate of clinical trials and also eradicated the cost of length research and development in drug discovery. Another factor which can bolster the anticipated growth of the Global AI for the drug discovery market is the lack of skilled health care professionals.

Currently, only one out of ten drugs are approved after clinical trials. Mostly because of lack of effectiveness and safety issues. Considering the growing cost of bringing a drug into the market, a minimum of ten percent improvement in the prediction of accuracy can save billions of dollars invested on drug development for AI in Drug Discovery vendors which compensate for both the residential as well as commercial sectors. So, improving the accuracy of predictions on the efficacy and safety of drugs is highly required. With a predicted CAGR of 43.24%, we have a lot of opportunities at our disposal and this report will help in understanding the current market dynamics, changing needs, and innovations that might be needed to make the user experience enriching.

This report would be the foundation for any research on the AI in Drug Discovery, vendor capabilities, SWOT of the vendors and framework for data analysis for further advanced innovation

An insight to the major competitors in the market, their journey and the competitive edge which one should have to beat other players is given

The report contains an understanding of technological innovations and advanced solutions for the AI in Drug Discovery.

Contents

Executive Summary
Industry Outlook
Industry Overview
Industry Trends
Market Snapshot
Market Definition
Market Outlook
PEST Analysis
Porter Five Forces
Related Markets
Market Characterisitics
Market Evolution
Market Trends and Impact
Advantages/Disadvantages of Market
Regulatory Impact
Market Offerings
Market Segmentation
Market Dynamics
Drivers
Restraints
Opportunities
DRO - Impact Analysis
End User: Market Size & Analysis
Overview
Research Centers and Academic & Government Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Application: Market Size & Analysis
Overview
Cardiovascular Diseases
Metabolic Diseases
Neurodegenerative Diseases
Immuno-oncology
Other Applications
Technology: Market Size & Analysis
Overview
Machine Learning
Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Other Machine Learning Technlogies
Others Technologies
Offering: Market Size & Analysis
Overview
Services
Software
Geography: Market Size & Analysis
Overview
North America
Europe
Asia Pacific
Rest of the World
Competitive Landscape
Competitor Comparison Analysis
Market Developments
Mergers and Acquisitions, Legal, Awards, Partnerships
Product Launches and execution
Vendor Profiles
Microsoft Corporation
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
NVIDIA Corporation
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
IBM Corporation
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Google
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Atomwise, Inc
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Deep Genomics
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Cloud Pharmaceuticals, Inc
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Insilico Medicine
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Benevolentai
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Exscientia
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Companies to Watch
Cyclica
Overview
Market
Business Strategy
Bioage
Overview
Market
Business Strategy
Numerate
Overview
Market
Business Strategy
Numedii, Inc.
Overview
Market
Business Strategy
Envisagenics
Overview
Market
Business Strategy
Twoxar, Incorporated
Overview
Market
Business Strategy
Owkin, Inc
Overview
Market
Business Strategy
Xtalpi, Inc
Overview
Market
Business Strategy
Verge Genomics
Overview
Market
Business Strategy
Berg LLC
Overview
Market
Business Strategy
Analyst Opinion
Annexure
Report Scope
Market Definitions
Research Methodology
Data Collation and In-house Estimation
Market Triangulation
Forecasting
Report Assumptions
Declarations
Stakeholders
Abbreviations

List Of Tables

LIST OF TABLES

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
MICROSOFT CORPORATION.: OVERVIEW
MICROSOFT CORPORATION.: STRATEGIC SNAPSHOT
MICROSOFT CORPORATION.: BUSINESS OPPORTUNITIES AND OUTLOOK
MICROSOFT CORPORATION.: PRODUCT/SERVICE PORTFOLIO
NVIDIA CORPORATION: OVERVIEW
NVIDIA CORPORATION: STRATEGIC SNAPSHOT
NVIDIA CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
NVIDIA CORPORATION: PRODUCT/SERVICE PORTFOLIO
IBM CORPORATION: OVERVIEW
IBM CORPORATION: STRATEGIC SNAPSHOT
IBM CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
IBM CORPORATION: PRODUCT/SERVICE PORTFOLIO
GOOGLE: OVERVIEW
GOOGLE: STRATEGIC SNAPSHOT
GOOGLE: BUSINESS OPPORTUNITIES AND OUTLOOK
GOOGLE: PRODUCT/SERVICE PORTFOLIO
ATOMWISE, INC: OVERVIEW
ATOMWISE, INC: STRATEGIC SNAPSHOT
ATOMWISE, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
ATOMWISE, INC: PRODUCT/SERVICE PORTFOLIO
DEEP GENOMICS: OVERVIEW
DEEP GENOMICS: STRATEGIC SNAPSHOT
DEEP GENOMICS: BUSINESS OPPORTUNITIES AND OUTLOOK
DEEP GENOMICS: PRODUCT/SERVICE PORTFOLIO
CLOUD PHARMACEUTICALS, INC: OVERVIEW
CLOUD PHARMACEUTICALS, INC: STRATEGIC SNAPSHOT
CLOUD PHARMACEUTICALS, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
CLOUD PHARMACEUTICALS, INC: PRODUCT/SERVICE PORTFOLIO
INSILICO MEDICINE.: OVERVIEW
INSILICO MEDICINE.: STRATEGIC SNAPSHOT
INSILICO MEDICINE.: BUSINESS OPPORTUNITIES AND OUTLOOK
INSILICO MEDICINE.: PRODUCT/SERVICE PORTFOLIO
BENEVOLENTAI: OVERVIEW
BENEVOLENTAI: STRATEGIC SNAPSHOT
BENEVOLENTAI: BUSINESS OPPORTUNITIES AND OUTLOOK
BENEVOLENTAI: PRODUCT/SERVICE PORTFOLIO
EXSCIENTIA.: OVERVIEW
EXSCIENTIA.: STRATEGIC SNAPSHOT
EXSCIENTIA.: BUSINESS OPPORTUNITIES AND OUTLOOK
EXSCIENTIA.: PRODUCT/SERVICE PORTFOLIO

List Of Figures

LIST OF FIGURES

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR METABOLIC DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR IMMUNOONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR TECHNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR MACHINE LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR DEEP LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR REINFORCEMENT LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR UNSUPERVISED LEARNING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR OFFERING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EXSCIENTIA.: SWOT ANALYSIS
CYCLICA: SWOT ANALYSIS
BIOAGE: SWOT ANALYSIS
NUMERATE: SWOT ANALYSIS
NUMEDII, INC: SWOT ANALYSIS
ENVISAGENICS.: SWOT ANALYSIS
TWOXAR, INCORPORATED: SWOT ANALYSIS
OWKIN, INC.: SWOT ANALYSIS
XTALPI, INC: SWOT ANALYSIS
VERGE GENOMICS.: SWOT ANALYSIS